Subsequently, the connection between adiponectin and mortality has been replicated in studies with much larger samples and other clinical settings, such as ischemic heart disease, type 1 and type 2 diabetes, end-stage renal disease, and even in the general elderly population (49–51). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.